SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Tekla Life Sciences Investors – ‘POS AMI’ on 10/15/14

On:  Wednesday, 10/15/14, at 11:41am ET   ·   Accession #:  1104659-14-71722   ·   File #:  811-06565

Previous ‘POS AMI’:  ‘POS AMI’ on 12/28/12   ·   Latest ‘POS AMI’:  This Filing

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

10/15/14  Tekla Life Sciences Investors     POS AMI                2:34K                                    Merrill Corp-MD/FA

Post-Effective Amendment
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: POS AMI     Post-Effective Amendment                            HTML     15K 
 2: EX-99.B(A)(XIV)  Miscellaneous Exhibit                          HTML     16K 


POS AMI   —   Post-Effective Amendment


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 

(As filed with the Securities and Exchange Commission on October 15, 2014)

 

Investment Company Act File No. 811-06565            

 

 

 

U.S. SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.

 

FORM N-2

 

Registration Statement Under the Investment Company Act of 1940

Amendment No. 16

 

H&Q LIFE SCIENCES INVESTORS

(Exact Name of Registrant as Specified in Charter)

 

2 Liberty Square, 9th Floor, Boston, MA 02109

(Address of Principal Executive Offices)

 

(617) 772-8500

(Registrant’s Telephone Number, including Area Code)

 

Daniel R. Omstead, Ph.D.

2 Liberty Square, 9th Floor, Boston, MA 02109

(Name and Address of Agent for Service)

 

Copies of Communications to:

 

Joseph R. Fleming, Esq.

Dechert LLP

One International Place, 40th Floor

100 Oliver Street

Boston, MA 02110

 

This amendment is being filed solely to file Exhibit No. (a)(xiv) to this Registration Statement relating to the Declaration of Trust.

 

 

 



 

PART C

OTHER INFORMATION

 

Amendment No. 3 to the Registrant’s Amended and Restated Declaration of Trust, as approved by the Registrant’s Board of Trustees by unanimous written consent of the Registrant on September 30, 2014, is filed herewith as Exhibit (a)(xiv).

 

SIGNATURES

 

Pursuant to the requirements of the Investment Company Act of 1940, the Registrant has duly caused this Amendment No. 16 to its Registration Statement under the Investment Company Act of 1940 to be signed on its behalf by the undersigned thereunto, duly authorized, in the Commonwealth of Massachusetts, on the 15th day of October, 2014.

 

 

H&Q LIFE SCIENCES INVESTORS

 

 

 

By: /s/ Daniel R. Omstead

 

Daniel R. Omstead

 

President

 

EXHIBIT INDEX

 

Exhibit No.

 

Description

 

 

 

(a)(xiv)

 

Amendment No. 3 to the Amended and Restated Declaration of Trust, as approved by the Registrant’s Board of Trustees.

 



Dates Referenced Herein

This ‘POS AMI’ Filing    Date    Other Filings
Filed on:10/15/14None on these Dates
9/30/14
 List all Filings
Top
Filing Submission 0001104659-14-071722   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Apr. 19, 4:53:12.2pm ET